Actavis (NYSE: ACT) will pay a premium of approximately $25 billion in cash and stock to acquire Forest Laboratories Inc. (NYSE: FRX). Shares of Forest Laboratories jumped $20.38 to $91.78 while Actavis stock leaped $12.15 to $204.03.
Actavis Buys Forest Labs For $25 Billion
February 18, 2014 at 14:20 PM EST